Tirzepatide: A New Anti-Obesity Medication in Little Elm, TX
Obesity is a serious health condition that can be associated with some of the leading causes of death, like cardiovascular disorders. The rates at which both obesity and overweight in the United States are rising are quite alarming. Recently, the FDA has approved Tirzepatide injection (Zepbound) for chronic weight management in adults with obesity with a body mass index of 30 kg/m2 or greater as well as overweight individuals with a body mass index of 27 kg/m2 or greater and having at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol.
